FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and concerns an anxiolytic agents of benzodiazepines group. Therapeutic composition in form of solution for intravenous and intramuscular introduction, comprising as an active substance bromo-dihydrochlor-phenyl-benzodiazepine and additive agents, characterised by that as an auxiliary agents contains polyvinyl pyrrolidone low-molecular medical (molecular weight 12,600±2,700), glycerol, sodium disulfite, polysorbate-80, sodium hydrogen phosphate dodecahydrate, potassium dihydrogen phosphate, sodium hydroxide solution 0.1 M and water for injections. Described also a method of producing a solution.
EFFECT: invention provides higher stability of the preparation.
6 cl, 4 ex, 2 tbl
